Suchergebnisse - "Dejnirattisai, Wanwisa"

PubPharm (33)

1

The SARS-CoV-2 neutralizing antibody response to SD1 and its evasion by BA.2.86

enthalten in: Nature communications | 2024

von Zhou, D. | Supasa, P. | Liu, C. | +14

2

Accelerating drug target inhibitor discovery with a deep generative foundation model

enthalten in: Science advances | 2023

von Chenthamarakshan, V. | Hoffman, S. | Owen, C. | +17

3

Protection against SARS-CoV-2 Omicron BA.4/5 variant following booster vaccination or breakthrough infection in the UK

enthalten in: Nature communications | 2023

von Wei, J. | Matthews, P. | Stoesser, N. | +75

4

Effect of priming interval on reactogenicity, peak immunological response, and waning after homologous and heterologous COVID-19 vaccine schedules : exploratory analyses of Com-COV, a randomised control trial

enthalten in: The Lancet. Respiratory medicine | 2022

von Shaw, R. | Liu, X. | Stuart, A. | +82

5

Fatal COVID-19 outcomes are associated with an antibody response targeting epitopes shared with endemic coronaviruses

enthalten in: JCI insight | 2022

von McNaughton, A. | Paton, R. | Edmans, M. | +54

6

SARS-CoV-2 antibody trajectories after a single COVID-19 vaccination with and without prior infection

enthalten in: Nature communications | 2022

von Wei, J. | Matthews, P. | Stoesser, N. | +76

7

Potent cross-reactive antibodies following Omicron breakthrough in vaccinees

enthalten in: Cell | 2022

von Nutalai, R. | Zhou, D. | Tuekprakhon, A. | +33

8

Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK : Three month analyses of the COV-BOOST trial

enthalten in: The Journal of infection | 2022

von Liu, X. | Munro, A. | Feng, S. | +56

CommentIn: J Infect. 2023 Feb;86(2):154-225. - PMID 36509358

9

Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001) : a phase 4, non-inferiority, single blind, randomised study

enthalten in: Lancet (London, England) | 2022

von Costa Clemens, S. | Weckx, L. | Clemens, R. | +44

CommentIn: Lancet. 2022 Feb 5;399(10324):496-497. - PMID 35074137

10

The antibody response to SARS-CoV-2 Beta underscores the antigenic distance to other variants

enthalten in: Cell host & microbe | 2022

von Liu, C. | Zhou, D. | Nutalai, R. | +28